Op-Ed Halves Drug Price
7:26–7:54 · 28s
After Memorial Sloan Kettering doctors publish a fiery New York Times op-ed, the manufacturer of Zaltrap slashes its price nationwide by 50% within weeks.
7:26–7:54 · 28s
After Memorial Sloan Kettering doctors publish a fiery New York Times op-ed, the manufacturer of Zaltrap slashes its price nationwide by 50% within weeks.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.